期刊文献+

胃肠胰神经内分泌肿瘤的临床病理特点及其与预后的关系 被引量:5

Gastroenteropancreatic neuroendocrine neoplasms: Clinicopathologic characteristics and their correlation with prognosis
下载PDF
导出
摘要 目的:分析胃肠胰神经内分泌肿瘤(gastroenteropancreafic neuroendocrine neoplasm,GEPNEN)的临床病理特点及其与预后的关系.方法:收集哈尔滨医科大学附属肿瘤医院2007-04/2013-04通过病理诊断为GEP-NEN的患者资料,Kaplan-Meier法进行生存分析,Logrank法比较临床病理特点与预后的关系,多因素Cox回归分析影响患者预后的独立危险因素结果:43例患者的平均年龄为57.5岁,男女性别比为2.91∶1.原发部位中以胃部最多(19例,44.19%).2例为功能性的GEP-NEN(1例为胰高血糖素瘤,1例出现类癌综合征).有14例术后经过药物治疗.43例患者中死亡22例(52.38%),失访1例(2.38%).患者1、3年生存率分别为70.2%、36.9%,中位总生存期为16.0mo.单因素分析显示:肿瘤大小(≥5 cm)、T分期、淋巴结转移、远处转移以及病理类型为神经内分泌癌(neuroendocrine carcinoma N E C)、混合性腺神经内分泌癌(m i x e d adenoneuroen docrine carcinoma,MANEC)影响患者的预后(P<0.05).患者年龄、性别、吸烟史、饮酒史、肿瘤家族史、手术方式及术后药物治疗与预后无相关性.多因素分析显示:淋巴结转移、远处转移及病理类型是预后的独立危险因素.结论:胃是GEP-NEN最常见的原发部位,临床表现无特异性.淋巴结转移、远处转移及病理类型是预后的独立危险因素. AIM: To analyze the clinicopathologic character- istics of gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) and their correlation with prognosis. METHODS: Clinical data for 43 patients diag- nosed pathologically with GEP-NEN in Har- bin Medical University Cancer Hospital from April 2007 to April 2013 were retrospectively analyzed. Survival analysis was performed by Kaplan-Meier method. The relationship between clinicopathologic characteristics and prognosis was analyzed using the Log-rank test. Indepen- dent risk factors for prognosis were analyzed by multivariate Cox regression analysis.RESULTS: The mean age was 57.5 years, with a male-to-female ratio of 2.91:1. The most com- mon site was stomach (19 cases, 44.19%). There were 2 cases of functional GEP-NEN (one case of glucagonoma and another case of carcinoid syn- drome). Of the 43 patients, 14 received postop- erative drug therapy. There were 22 deaths in 43 patients (52.38%) and one case (2.38%) was lost to follow-up. The 1- and 3-year survival rates were 70.2% and 36.9%, with a median overall survival (OS) of 16.0 months. Univariate analysis showed that tumor size (≥5 cm), depth of inva- sion, lymph node metastasis, distant metastasis and pathological grades of NEC (neuroendocrine carcinoma) and MANEC (mixed adenoneuroen docrine carcinoma) could affect the patient's prognosis (P 〈 0.05 for all). Age, gender, smok- ing, drinking, family history of cancer, surgical approach and postoperative drug therapy were not significantly associated with prognosis. Mul- tivariate analysis showed that lymph node me- tastasis, distant metastasis and pathological type were independent risk factors. CONCLUSION: The stomach is the most com- mon primary site of GEP-NEN, and GEP-NEN lacks specific clinical manifestations. Lymph node metastasis, distant metastasis and patho- logical type are independent risk factors.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第6期846-852,共7页 World Chinese Journal of Digestology
基金 黑龙江省青年科学基金资助项目 No.QC2012C011~~
关键词 胃肠胰神经内分泌肿瘤 临床病理 预后 Gastroenteropancreatic neuroendocrineneoplasm Clinical pathology Prognosis
  • 相关文献

参考文献6

二级参考文献26

  • 1Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 2Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.
  • 3Raymond E,Dahan L,Raoul JL,et al.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.N Engl J Med,2011,36(6):501-513.
  • 4Kl(o)ppel G,Couvelard A,Perren A,et al.ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.Neuroendocrinology,2009,90 (2):162-166.
  • 5Klimstra DS,Modlin IR,Adsay NV,et al.Pathology reporting of neuroendocrine tumors:application of the Delphic consensus process to the development of a minimum pathology data set.Am J Surg Pathol,2010,34(3):300-313.
  • 6Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system.Lyon:IARC Press,2010.
  • 7Oberndorfer S.Karzinoide tumoren des dunndarms.Frankf ZPatrol,1907,1:426-432.
  • 8Williams ED,Siebenmann RE,Sobin LH.Histological typing of endocrine tumours.Geneva:World Health Organization,1980.
  • 9Hamilton SR,Aaltonen LA.World Health Organization classification of tumours.Pathology and genetics of tumours of the digestive system.Lyon:IARC Press,2000.
  • 10Rindi G,Kl(o)ppel G,Alhman H,et al.TNM staging of foregut (neuro) endocrine tumors:a consensus proposal including a grading system.Virchows Arch,2006,449(4):395-401.

共引文献339

同被引文献52

  • 1Bosman FT, Carneiro F, Hruban RH, Theise ND. World Health Organization classification of tumours of the digestive system. Lyon: IARC Press, 2010: 1-155.
  • 2Estrozi B, Bacchi CE. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Clinics (Sao Paulo) 2011; 66: 1671-1675 PubMed.
  • 3Huang Q, Wu H, Nie L, Shi J, Lebenthal A, Chen J, Sun Q, Yang J, Huang L, Ye Q. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol 2013; 37: 467-483 PubMed DOI.
  • 4Schuerle T, Aoun E, Farah K. Small cell carcinoma of the oesophagus: a rare cause of dysphagia. BMJ Case Rep 2013; 2013 Sep 3. pii: bcr2013200468 PubMed DOI.
  • 5Wang ZB, Peng XZ, Chen SS, Ning FL, Du CJ, Wang K, Ma W, Cheng YF. High p53 and MAP1 light chain 3A co-expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Mol Med Rep 2013; 8: 41-46 PubMed DOI.
  • 6Namikawa T, Oki T, Kitagawa H, Okabayashi T, Kobayashi M, Hanazaki K. Neuroendocrine carcinoma of the stomach: clinicopathological and immunohistochemical evaluation. Med Mol Morphol 2013; 46: 34-40 PubMed DOI.
  • 7Alvarado-Cabrero I, de Anda-González J, Hernández-Hernández B, Mantilla-Morales A, Valencia-Cedillo R, Medrano-Guzmán R. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital]. Rev Gastroenterol Mex 2012; 77: 174-180 PubMed DOI.
  • 8Terada T. Small cell neuroendocrine carcinoma of the esophagus: report of 6 cases with immunohistochemical and molecular genetic analysis of KIT and PDGFRA. Int J Clin Exp Pathol 2013; 6: 485-491 PubMed.
  • 9Modlin IM,Kidd.Current status of gastrointestinal carcinodis[J].Gastroenterology,2005,128(6):1717-1751.
  • 10Scheruebl H.Rectal carcinoids are on the rise;early detection by screening endoscopy[J].Endoscopy,2009,41(2):162-165.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部